FMRI under sedation: what is the best choice in children?

Byron Bernal1, Sandra Grossman, Rafael Gonzalez

  • 1Department of Radiology, Miami Children's Hospital, USA.

Insights

Comparing sedation methods for pediatric fMRI in epilepsy surgery, this study found no significant difference in brain activation. Pentobarbital and propofol showed fewer failures but pentobarbital had more side effects.

Area of Science:

  • Pediatric neuroimaging
  • Anesthesiology
  • Epilepsy surgery

Background:

  • Pediatric functional magnetic resonance imaging (fMRI) often necessitates sedation.
  • Evaluating sedation efficacy is crucial for successful pediatric neuroimaging in epilepsy surgery evaluations.

Purpose of the Study:

  • To compare different sedation regimens for pediatric fMRI.
  • To determine which medication yields the fewest procedural failures and optimal brain activation.

Main Methods:

  • 100 children undergoing fMRI for epilepsy surgery workup were divided into groups receiving Pentobarbital, Propofol, Dexmedetomidine, or Sevoflurane.
  • Outcomes assessed included failure rates, activation rank, adverse effects, anesthesia, and recovery times.
  • BOLD sequences and block-design paradigms (auditory, visual) were used, with activation ranked into five categories. Statistical analysis included ANOVA.

Main Results:

  • Pentobarbital showed the fewest failures for the auditory task, followed by Propofol. Sevoflurane had the highest failure rate for both tasks.
  • For the visual task, Propofol after Dexmedetomidine yielded the fewest failures.
  • No statistically significant differences in brain activation were observed between groups for either task (auditory: P = 0.42; visual: P = 0.077).
  • Sevoflurane offered the shortest recovery time, followed by Propofol. Pentobarbital was associated with agitation and cardiac complications in 28% of cases.

Conclusions:

  • Different sedative medications did not produce statistically significant differences in brain activation during pediatric fMRI for intractable epilepsy.
  • A trend towards fewer failures was noted with Pentobarbital and Propofol.
  • Pentobarbital was linked to a higher incidence of adverse effects, despite a trend toward fewer failures.
Abstract